Last reviewed · How we verify
Isatuximab SC (isatuximab-sc)
Isatuximab SC (generic name: isatuximab-sc) is a Monoclonal antibody drug developed by Pfizer Inc.. It is currently FDA-approved.
At a glance
| Generic name | isatuximab-sc |
|---|---|
| Sponsor | Pfizer Inc. |
| Modality | Monoclonal antibody |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma (PHASE1, PHASE2)
- ELISA in Relapsed/Refractory MM (PHASE2)
- A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (PHASE2)
- Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma (PHASE3)
- Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis (PHASE1)
- A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments (PHASE1)
- SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM (PHASE3)
- Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Isatuximab SC CI brief — competitive landscape report
- Isatuximab SC updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about Isatuximab SC
What is Isatuximab SC?
Isatuximab SC (isatuximab-sc) is a Monoclonal antibody drug developed by Pfizer Inc..
Who makes Isatuximab SC?
Isatuximab SC is developed and marketed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).
What is the generic name of Isatuximab SC?
isatuximab-sc is the generic (nonproprietary) name of Isatuximab SC.
What development phase is Isatuximab SC in?
Isatuximab SC is FDA-approved (marketed).
Related
- Manufacturer: Pfizer Inc. — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing